15:10 EDT Sarepta (SRPT) trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Sarepta price target lowered to $10 from $23 at RBC Capital
- Sarepta needs to prove Elevidys won’t cause more deaths, Bloomberg says
- FDA official: Sarepta needs new studies to bring Elevidys back, Endpoints says
- Positive Long-Term Outlook for Sarepta Therapeutics Amid Regulatory Challenges
- Sarepta price target lowered to $35 from $40 at Jefferies